NBIO — Nascent Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Nascent Biotech, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	0.003	0.001	0.094	0.172	0.372
Net Total Accounts Receivable
Net Total Receivables	—	0.75	0	—	—
Prepaid Expenses
Total Current Assets	0.003	0.751	0.105	0.255	0.552
Total Assets	0.003	0.751	0.105	0.255	0.552
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.88	1.22	0.777	1.55	0.809
Total Long Term Debt
Total Debt
Total Liabilities	2.88	1.22	0.777	1.55	0.809
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-2.88	-0.473	-0.671	-1.3	-0.257
Total Liabilities & Shareholders' Equity	0.003	0.751	0.105	0.255	0.552
Total Common Shares Outstanding
Total Preferred Shares Outstanding